John Pirault

John Pirault is a seasoned scientific leader with extensive expertise in immunology and biomarker-functional assays, currently serving at Charles River Laboratories since January 2019. Responsibilities include conducting assessments of immunotoxicology for drug safety, ensuring GLP compliance, and advising sponsors on experimental designs and flow cytometry expertise. Prior experience includes a postdoctoral role at Inserm, leading a project on inflammation and arterial stiffness, and a project at Karolinska Institutet focusing on radiotherapy-induced cardiotoxicity. John completed a PhD at Inserm studying macrophage roles in diseases, complemented by teaching roles at Pierre and Marie Curie University. John holds a Master's degree in molecular and cellular biology with a focus on immunology.